Advertisement

Topics

Oasmia Pharmaceutical AB: Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia

02:52 EDT 8 Aug 2017 | FinanzNachrichten

Uppsala, Sweden, 2017-08-08 08:40 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today th...

Original Article: Oasmia Pharmaceutical AB: Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia

NEXT ARTICLE

More From BioPortfolio on "Oasmia Pharmaceutical AB: Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...